It was on the benefits of lupercerne for treatment of prostate cancer.good results of trials in Norway.im not sure what lupercerne is so asked for help in understanding !! I have 41 million shares in this company and really believe in it.thanks for your condesending attitude Dutch gold it really encourages posting.on this site
Hence, it is in DSM''s interest to help get Provexis into making a healthy profit as quickly as possible so they can then put a bid in for Provexis; Hence, last year, a year in advance, DSM back dated the revenue share agreement to January 2015; and as the number of Fruitflow products keeps growing our revenues from DSM should keep growing and growing. We need an update from Provexis that our revenues is now growing and growing and then hopefully our share price will move on up and up until DSM then puts a bid in based on growing value of Provexis; and DSM can then get on with its global launch of its new Fruitflow and Omega 3 product. IMHO
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.